Posts Tagged ‘Switzerland’
Lunaphore and CRO Sirona Dx collaborate to expand COMET™ offerings to US-based biotech and biopharma customers
Sirona Dx will become the first US-based Contract Research Organization (CRO) to offer Lunaphore’s flagship COMET™ spatial biology platform as a service. Lunaphore, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, and Sirona Dx, a leader in multi-omics, single-cell analytical services, today announced a strategic collaboration in which Sirona Dx will become…
Read MoreTerapet raises CHF 2,3 million
The Swiss MedTech company is developing next generation imaging technology, and closed a Pre-Series A investment round. This funding supports the commercialization of Terapet’s first product, Qualγscan and the development of new nuclear imaging products. The funding round was co-led by EFI Lake Geneva Ventures and Nina Capital with support of all the existing…
Read More7 digital health start-ups selected by the Future of Health Grant
CSS and EPFL announce the 2nd cohort of the Future of Health Program The Future of Health Grant (FoHG) programme of CSS and EPFL Innovation Park supports innovation in digital health. The 7 new start-ups selected from 96 applications will receive funding and expertise to accelerate the development of their solution. 7 start-ups…
Read MoreLonza wants to encourage careers In Life Sciences and opens MINTWorld
Faced with a shortage of qualified personnel in the field of mathematics, computer science, natural sciences and technology (MINT) in the Swiss Health Valley, Lonza and the Department of Economy and Education (DEF) of the canton of Valais have joined forces to create a discovery and innovation space for the promotion of MINT. Located…
Read MoreGene Predictis is bought by NIMGenetics
The EPFL-based start-up accepted the offer of the Spanish company. The amount of the transaction has not been disclosed. NIMGenetics, a leading Spanish biotechnology company in the field of human genetic diagnostics, continues its expansion in Europe with the acquisition of the Swiss diagnostic company Gene Predictis, a leader in the field of preventive…
Read MoreAspivix receives U.S. FDA Clearance for Carevix™, Their Novel Cervical Stabilizer
Carevix™, a novel atraumatic cervical stabilizer created by the Swiss startup ASPIVIX SA, received 510(k) clearance from the U.S. Food and Drug Administration (FDA). A more gentle and efficient tool for gynecology. Carevix™ is an atraumatic cervical stabilizer that utilizes a gentle approach to reduce pain and bleeding in multiple transcervical procedures, such as…
Read MoreLimula and CSEM partner to automate the production of CAR T cells
A Health Valley partnership to revolutionize cancer therapies and to bring a personalised treatment for cancer patients CSEM supports Lausanne-based start-up Limula in its mission to make cell therapies more affordable. The technology developed enables the automated production of CAR T and other cell therapies at scale. The prototype is now going towards pre-industrial…
Read More€2M Eurostars funding for a project led by Calciscon
CALCISCON, AMSTERDAM UNIVERSITY MEDICAL CENTERS and ADMESY have signed a collaborative agreement for the development of a laboratory benchtop analyzer for the measurement of the T50 test. T50 is a unique test for the measurement of calcification propensity in a blood sample. The primary use of T50 is to revolutionize the treatment of patients…
Read MoreXsensio announces an agreement with Mayo Clinic
Xsensio Announces Know-How and Stock Purchase Agreement with Mayo Clinic Xsensio, a Vaud-Based company that is developing the Lab-on-Skin© sensing platform, announced that it has entered into a know-how and stock purchase agreement with Mayo Clinic for the development of new wearable products based on short term health dynamics in critical care. Xsensio will…
Read MoreComphya raises CHF 850 000 in a convertible loan
Comphya SA, developer of the first neuromodulator to treat erectile dysfunction (ED), announced the fundraising of CHF 850k in a convertible loan. This brings the total amount of funds raised to CHF 5.1 Mio. The financial round included investment from existing shareholders and additional investors. Praxis Spinal Cord Institute, a non-profit organization, also committed…
Read More